000 | 01919 a2200529 4500 | ||
---|---|---|---|
005 | 20250513104008.0 | ||
264 | 0 | _c19970227 | |
008 | 199702s 0 0 eng d | ||
022 | _a1058-4838 | ||
024 | 7 |
_a10.1093/clinids/23.4.767 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTornieporth, N G | |
245 | 0 | 0 |
_aRisk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. _h[electronic resource] |
260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cOct 1996 |
||
300 |
_a767-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aCephalosporins _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
650 | 0 | 4 | _aEnterococcus faecium |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aLength of Stay |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aVancomycin _xadverse effects |
700 | 1 | _aRoberts, R B | |
700 | 1 | _aJohn, J | |
700 | 1 | _aHafner, A | |
700 | 1 | _aRiley, L W | |
773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 23 _gno. 4 _gp. 767-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/clinids/23.4.767 _zAvailable from publisher's website |
999 |
_c8902342 _d8902342 |